An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).
If the findings are confirmed in more extensive clinical trials, the surgery could offer hope to patients with high blood pressure who do not respond to drugs, and are at increased risk of cardiovascular diseases, including stroke and heart attack.
The international clinical trial, carried out from 2017 to 2018 at St Bartholomew’s Hospital in the UK by the NIHRBarts Biomedical Research Centre, tested a one-hour operation called ‘renal denervation’, which uses ultrasound energy to disrupt the nerves between the kidneys and the brain that carry signals for controlling blood pressure.
Significant reduction in blood pressure
146 patients in the United States, France, Germany, the Netherlands, Belgium and the United Kingdom were randomised to receive either renal denervation or a ‘sham procedure’ – the surgical equivalent of a placebo. Patients also remained off blood pressure medications for two months unless specified blood pressure levels were exceeded.
After two months, the renal denervation group experienced an 8.5 mm Hg reduction in blood pressure, which was a 6.3 mm Hg greater reduction compared with the sham group.
More than 66 per cent of subjects treated with renal denervation demonstrated a 5 mm Hg or greater reduction in blood pressure, compared with 33 per cent in the sham group.
No major adverse events were reported in either group, and the blood pressure lowering effect of renal denervation was consistent across sex and ethnicity.
An alternative to lifelong medications
UK Principal Investigator Dr Melvin Lobo from Queen Mary’s William Harvey Research Institute and Barts Health NHS Trust said: “These results leave us clinicians in no doubt that this ultrasound-based therapy works to improve blood pressure control – at least in the short term. Further larger trials will be needed to confirm the efficacy and safety of the technology, but we hope that they could lead to renal denervation therapy being offered as an alternative to lifelong medications for hypertension.”
The study has limitations including the short follow-up time of two months. This was done for safety reasons to minimise the duration of patients being off antihypertensive medications. Longer follow-up of this trial and additional numbers of treated patients will be necessary to provide greater assurance of safety and to exclude rare adverse events.
The Latest on: Hypertension
via Google News
The Latest on: Hypertension
- Study finds common hypertension drug doesn't slowdown advanced Alzheimer's progressionon December 5, 2021 at 8:34 am
The drug losartan normally used to treat high blood pressure or hypertension does not effect in slowing down the progression of Alzheimer disease AD in peo ...
- 5 Penny Stocks To Buy For Under $5 Right Nowon December 5, 2021 at 8:30 am
Are These Penny Stocks On Your Watch List? If you’re making a penny stocks watch list, you’re not alone. Right now, there are hundreds of penny stocks to choose from ...
- Chronic exposure to particulate matter linked with high blood pressureon December 4, 2021 at 8:31 pm
According to the WHO, air pollution is the greatest health risk worldwide, accounting for more than 4.2 million deaths annually.
- Preterm Deliveries and Hypertension: Examining two sides of a studyon December 4, 2021 at 3:30 pm
Dr Mgha Consul and Dr Prasanna Latha discuss two sides of the study on preterm delivery. Name of study: Preterm delivery has been associated with a high risk of hypertension in the future By who and ...
- Link Between Maternal Hypertension and Birth Weighton December 4, 2021 at 7:43 am
Researchers investigated how low birth weight and fetal growth restriction may result from the mother having certain variants of hypertension-related genes.
- Adolescent arterial stiffness may be precursor of hypertension in young adulthoodon November 30, 2021 at 6:42 am
Arterial stiffness during adolescence may be a precursor of hypertension and obesity in young adulthood, researchers reported in Hypertension. “Arterial stiffness has mainly been considered a risk ...
- Using Remote Patient Monitoring to Lower Hypertension Progressionon November 29, 2021 at 4:57 am
Through remote patient monitoring, patients with hypertension treatment can access smoking cessation and weight management programs as well as services that address behavioral health and even sleep ma ...
- 1 in 5 people with hypertension take drugs that increase blood pressureon November 25, 2021 at 6:40 am
A study shows that 1 in 5 people in the United States with hypertension are taking medications that could raise their blood pressure.
- Hypertension linked to 2.5 times higher risk of epilepsyon November 23, 2021 at 8:45 am
New research suggests that hypertension may raise the risk of epilepsy by around 2.5 times but taking antihypertensive medications can lower this risk.
via Bing News